
    
      OBJECTIVE: The objective of this phase of the study is to allow the clinical site to gain
      familiarity with patient recruitment, sample and data collection, and interpretation of the
      proteogenomic biomarker report provided, through retrospective analysis. This phase of the
      study will provide a platform for the transplant physicians to gain confidence with the
      format, logistics, and potential use of the biomarker tests on blood and tissue.
    
  